Tal Zvi Zaks, Chief Medical Officer at Moderna, Inc. (MRNA), sold 8,700 shares at $166.31 ($1.4M) on 2021-04-19, disclosed to the SEC on 2021-04-20.
Open-market sale of $1.4M MRNA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $160.48 | 656 | $105K | 7.4% |
| 2 | $160.48 | 656 | $105K | 7.4% |
| 3 | $161.62 | 1,332 | $215K | 15.2% |
| 4 | $161.62 | 1,332 | $215K | 15.2% |
| 5 | $162.65 | 1,250 | $203K | 14.4% |
| 6 | $162.65 | 1,250 |
| $203K |
| 14.4% |
| 7 | $163.89 | 500 | $82K | 5.8% |
| 8 | $165.04 | 462 | $76K | 5.4% |
| 9 | $165.04 | 462 | $76K | 5.4% |
| 10 | $166.31 | 700 | $116K | 8.2% |
| 11 | $167.56 | 100 | $17K | 1.2% |
| Total | $162.68 avg | 8,700 | $1.4M | 100% |
| Filing → |
| MRNA | SELL | 2021-06-25 | $1.1M | — | Filing → |
| MRNA | SELL | 2021-06-21 | $1.0M | — | Filing → |
| MRNA | SELL | 2021-06-11 | $1.1M | — | Filing → |